Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov 2:12:62.
doi: 10.1186/1471-2172-12-62.

Differential expression of CD300a/c on human TH1 and TH17 cells

Affiliations

Differential expression of CD300a/c on human TH1 and TH17 cells

Venkateswara R Simhadri et al. BMC Immunol. .

Abstract

Background: Human memory CD4+ T cells can be either CD300a/c+ or CD300a/c- and subsequent analyses showed that CD4+ effector memory T (T(EM)) cells are mostly CD300a/c+, whereas CD4+ central memory T (T(CM)) cells have similar frequencies of CD300a/c+ and CD300a/c- cells.

Results: Extensive phenotypical and functional characterization showed that in both T(CM) and T(EM) cells, the CD300a/c+ subset contained a higher number of TH1 (IFN-γ producing) cells. Alternatively, TH17 (IL-17a producing) cells tend to be CD300a/c-, especially in the T(EM) subset. Further characterization of the IL-17a+ cells showed that cells that produce only this cytokine are mostly CD300a/c-, while cells that produce IL-17a in combination with other cytokines, especially IFN-γ, are mostly CD300a/c+, indicating that the expression of this receptor is associated with cells that produce IFN-γ. Co-ligation of the TCR and CD300a/c in CD4+ T cells inhibited Ca2+ mobilization evoked by TCR ligation alone and modulated IFN-γ production on TH1 polarized cells.

Conclusion: We conclude that the CD300a/c receptors are differentially expressed on human TH1 and TH17 cells and that their ligation is capable of modulating TCR mediated signals.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow cytometric analysis of human peripheral blood CD4+ T cells. The expression of CD300a/c on central (TCM) and effector memory (TEM) CD4+ T cells was determined with three staining strategies: CD45RO and CD62L (upper panels), CD45RO and CD27 (middle panels) and CD45RA and CCR7 (lower panels). A representative donor is shown for each staining. Bar graphs represent the average ± SEM of the percentage of CD300a/c+ cells within TCM and TEM. Results shown are from 12 healthy donors.
Figure 2
Figure 2
Flow cytometric analyses of stimulated CD4+ T cells. Purified CD4+ T cells were stimulated with PMA and ionomycin for 4-5 h in the presence of GolgiStop (monensin). The expression of CD300a/c was determined in the TCM (CD45RO+CD27+) and TEM (CD45RO+CD27-) cytokine producing cells. A representative healthy donor is shown for (A) the IFN-γ, IL-4 and IL-17a, and (B) IL-2 and TNF-α producing cells. Each graph represents the percentage of CD300a/c+ and CD300a/c- TCM and TEM cells that produce a given cytokine. Each symbol corresponds to a different donor.
Figure 3
Figure 3
CD300a/c is differentially expressed on IFN-γ, TNF-α and IL-17a producing CD4+ T cells. (A) Purified CD4+ T cells were stimulated with PMA and ionomycin for 4-5 h in the presence of GolgiStop (monensin). Then, cells were stained for intracellular production of IFN-γ and IL-17a, and cell surface expression of CD300a/c. Analysis of cells from a representative donor is shown. The bar graphs represent the average ± SEM of the percentage of CD300a/c+ cells within the cytokine producing cells and the average ± SEM of the MFI of IFN-γ expression and IL-17a expression within the cytokine producing cells. Results are from 11 healthy donors. (B) Percentage of cells producing both IFN-γ and IL-17a within the IL-17a producing CD45RO+CD300a/c+ and CD45RO+CD300a/c- subsets is shown. Analysis of cells from a representative donor (left) and a graph (right) with the results for all donors are presented. (C) The experiments are the same as in A and B, except cells were stained for intracellular production of TNF-α and IL-17a.
Figure 4
Figure 4
IL-17a single producing cells tend to be CD300a/c-. Purified CD4+ T cells were stimulated with PMA and ionomycin for 4-5 h in the presence of GolgiStop (monensin). Then, cells were stained for cell surface expression of CD300a/c and intracellular production of IL-17a and other cytokines. A representative donor is shown for (A) IL-17a, for TNF-α and IFN-γ producing cells, (B) IL-17a, IL-2 and IFN-γ producing cells, and for (C) IL-17a, IL-2 and TNF-α producing cells. Graph bars represent the average ± SEM of the percentage of CD300a/c+ cells within the cytokine producing cells. Results are from 8-12 healthy donors.
Figure 5
Figure 5
CD300a/c modulates TCR mediated Ca2+ flux. CD4+ T cell lines were generated from healthy donors. Cells were loaded with Fluo-4 and Fura-Red. Then, cells were acquired in a flow cytometer, and after a baseline reading of 30 s, anti-CD3 plus anti-CD300a/c mAb or anti-CD3 plus isotype control mAb (black arrows) were added. Goat anti-mouse Ab was added 30 s later to cross-link the primary mAb (grey arrows). Intracellular Ca2+ concentration was measured by the ratio of Fluo-4/Fura Red as a function of time.

References

    1. Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112:1557–69. doi: 10.1182/blood-2008-05-078154. - DOI - PMC - PubMed
    1. Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, Yang SY, Murphy TL, Murphy KM. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol. 2002;3:549–57. - PubMed
    1. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med. 2005;202:1715–24. doi: 10.1084/jem.20051782. - DOI - PMC - PubMed
    1. Caspi R. Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunol Res. 2008;42:41–50. doi: 10.1007/s12026-008-8031-3. - DOI - PMC - PubMed
    1. Foulds KE, Wu CY, Seder RA. Th1 memory: implications for vaccine development. Immunol Rev. 2006;211:58–66. doi: 10.1111/j.0105-2896.2006.00400.x. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources